trial

A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy Volunteers

NCTId NCT01788436
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Early Phase 1 · Completed
Enrollment 51 (actual)
Sponsored by Janssen, L.P. - Investigator Initiated Studies Program
Primary completion 2014-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Early Phase 1
Status
Completed
Enrollment
51 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2012-11
Primary completion
2014-05
Eligibility
ALL · 18 Years · 85 Years

Interventions & indications

Drugs
Cognitive Test Battery 1Cognitive Test Battery 2

Sponsors

Janssen, L.P. - Investigator Initiated Studies ProgramLead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
51
Phase
EARLY_PHASE1
Primary Completion Date
2014-05
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Test Battery 1
drug
Cognitive Test Battery 2
drug
lead_sponsor
Janssen, L.P. - Investigator Initiated Studies Program
company
indication
Schizophrenia
indication
Schizophrenia
indication